Your search returned 36 studies. (Get alerts for new studies):
- Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Brain and Central Nervous System Tumors
Location: Odessa, Texas
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid - Osteoarthritis
Location: Midland, Texas
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid - Osteoarthritis
Location: Odessa, Texas
- RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Conditions: Heart Failure - Anemia - Cardiovascular Disease - Ventricular Dysfunction - Congestive Heart Failure
Location: Odessa, Texas
- Knee Articular Cartilage Debridement in Conjunction With Partial Meniscectomy
Conditions: Torn Meniscus - Articular Cartilage Defect
Location: Odessa, Texas
- Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Conditions: Lung Neoplasm - Carcinoma Non-small Cell Lung Cancer Stage IIIA - Carcinoma Non-small Cell Lung Cancer Stage IIIB - Carcinoma Non-small Cell Lung Cancer Stage IV
Location: Midland, Texas
- Chemotherapy and Radiation in Treating Patients With Stage 3 Non-Small Cell Lung Cancer
Conditions: Non Small Cell Lung Cancer
Location: Odessa, Texas
- Randomized Phase II Trial of Letrozole With or Without Dasatinib as First and Second-line Treatment for Hormone Receptor-positive, HER2-negative Post-
Conditions: Metastatic Breast Cancer
Location: Odessa, Texas
- A Study of Pemetrexed, Carboplatin and Bevacizumab in Patients With Nonsquamous Non-Small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer
Location: Midland, Texas
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: Odessa, Texas
- A Study for Patients With Pancreatic Cancer
Conditions: Pancreatic Neoplasms
Location: Midland, Texas
- Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Conditions: Non-Small Cell Lung Cancer - Anemia - Cancer - Lung Cancer
Location: Midland, Texas
- Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Conditions: Kidney Neoplasms
Location: Midland, Texas
- Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone
Conditions: Adenocarcinoma - Her2+ - Advanced Metastatic Breast Cancer - Metastatic ErbB2 - Invasive Breast Cancer - Advanced Breast Cancer - Cancer - ErbB2+
Location: Odessa, Texas
- Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma
Conditions: Multiple Myeloma
Location: Odessa, Texas
- Global Study Looking at the Combination of RAD001 Plus Best Supportive Care (BSC) and Placebo Plus BSC to Treat Patients With Advanced Hepatocellular
Conditions: Carcinoma
Location: Odessa, Texas
- A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 2
Location: Odessa, Texas
- Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Conditions: Chronic Lymphocytic Leukemia
Location: Midland, Texas
- Connect® MM- The Multiple Myeloma Disease Registry
Conditions: Multiple Myeloma
Location: Midland, Texas
- Connect® MM- The Multiple Myeloma Disease Registry
Conditions: Multiple Myeloma
Location: Odessa, Texas
- A Study in Head and Neck Cancer
Conditions: Head and Neck Cancer
Location: Odessa, Texas
- A Study of Pemetrexed & Carboplatin/Cisplatin or Gemcitabine & Carboplatin/Cisplatin With or Without IMC-1121B in Patients Previously Untreate
Conditions: Carcinoma, Non-Small-Cell Lung
Location: Midland, Texas
- A Study of Chemotherapy and Ramucirumab vs. Chemotherapy Alone in Second Line Non-small Cell Lung Cancer Patients Who Received Prior First Line Platin
Conditions: Non Small Cell Lung Cancer
Location: Midland, Texas
- A Study of Chemotherapy and Ramucirumab vs. Chemotherapy Alone in Second Line Non-small Cell Lung Cancer Patients Who Received Prior First Line Platin
Conditions: Non Small Cell Lung Cancer
Location: Odessa, Texas
- A Study in Second Line Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Odessa, Texas
- Study Comparing Orteronel Plus Prednisone in Patients With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer
Conditions: Prostate Cancer
Location: Midland, Texas
- Study Comparing Orteronel Plus Prednisone in Patients With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer
Conditions: Prostate Cancer
Location: Odessa, Texas
- Study Comparing Orteronel Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer
Conditions: Prostate Cancer
Location: Odessa, Texas
- Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Conditions: Chronic Myeloid Leukemia
Location: Midland, Texas
- Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Conditions: Chronic Myeloid Leukemia
Location: Odessa, Texas
- Effect of Vitamin D Replacement on Insulin Sensitivity
Conditions: Insulin Sensitivity
Location: Odessa, Texas
- Study of ACE-011 to Determine Safe and Effective Dose of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Advanced Non-small
Conditions: Anemia - Carcinoma, Non-Small-Cell Lung - Carcinoma, Small-Cell Lung - Bladder Cancer - Cancer of Head and Neck - Uterine Cervical Cancer
Location: Midland, Texas
- Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer
Conditions: Colorectal Cancer
Location: Midland, Texas
- Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Conditions: Atherosclerosis
Location: Odessa, Texas
- The BEACON Study (Breast Cancer Outcomes With NKTR-102)
Conditions: Locally Recurrent Breast Cancer - Metastatic Breast Cancer
Location: Midland, Texas
- A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovasc
Conditions: Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD)
Location: Odessa, Texas
|